Varizolomida
THERAPEUTIC AREA: Oncology
ACTIVE PRINCIPLE: Temozolamide
PRESENTATION: 250 mg x 5 capsules, 100 mg x 5 capsules or 20 mg x 5 capsules
INDICATION:
- Anaplastic Astrocytoma
- Multiform Globlastoma
- Malignant Glioma
COUNTRIES WHERE IT IS MARKETED:
